Medical Weight Loss

Revolutionary glucagon-like peptide-1 (GPL-1) receptor blocker medications help you kick start your weight loss journey. If you are obese with a Body Mass Index (BMI) of over 30 or overweight with a BMI of 27 and above and have other risk factors, you could qualify for our 12 weeks program. Medications such as Semaglutide and Mounjaro stimulate insulin secretion in a glucose-dependent manner, slow the gastric motility, increase insulin sensitivity, decrease glucagon secretion and improve early satiety.


  • Weight loss
  • Blood sugar control
  • Suppression of appetite
  • Improvement in cardiovascular health
  • Lowering of lipid levels

Injections are once a week done either virtually or in office for a minimum of 12 weeks.


  • Consultation
  • 3 months of medication and supplies
  • Monthly video consultations
  • Weekly virtual or in office injection administrations
  • Nutritional recommendations